Analogs of ceramide which inhibit galactocerebrosidase also demyelinate or inhibit myelination in organ cultures of rat cerebellum. The potency of the analogs in culture correlated with their effectiveness as inhibitors of cerebrosidase, but not with their effectiveness as inhibitors of galactosyl transferase. The most effective compound was the decanoyl amide of 3-phenyl-2-amino-l,3-propanediol with erythroconformation. Stimulators of cerebrosidase also demyelinated cultures. With both groups of compounds, myelin sheaths became distorted, then broke into lipid droplets. Axons were preserved, but neurons showed some nuclear changes and granularity. Metabolic studies with the most effective inhibitor showed that glucose incorporation into cerebroside and other alkali-stable lipids was initially depressed compared to proteins and total lipids.
INTRODUCTION
Arora, Lin and Radin have synthesized compounds, some of which inhibit 1,3 and some of which stimulate 4 the degradative enzyme galactosyl ceramide fl-galactosidase (cerebrosidase). These compounds are of general interest because they are among the first analogs available to interfere with specific steps of galactolipid metabolism. The compounds are of special interest because the enzyme they affect is markedly decreased in Krabbe's disease 21, a dysmyelinating disorder. Thus, the inhibitors may provide a unique opportunity to examine mechanisms by which * Present address and address for reprints: Department of Neurology, Wayne State University School of Medicine, Detroit, Mich. 48201, U.S.A.
